Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02269280 |
|---|---|
| Brief Title: | Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) |
| First Submitted : | October 13, 2014 |
| First Submitted that Met QC Criteria : | October 16, 2014 |
| First Posted : | October 21, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | July 21, 2020 |
| Last Update Posted : | July 22, 2020 |